QA: Artelo Biosciences INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2018_Artelo_Biosciences_INC.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001621221, Artelo Biosciences INC

  xvar xval
0 AssetsCurrent 574,275
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 29,438
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 107,533
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 125,256
11 remainder_Revenues 0
12 remainder_NetIncome -2,100
13 remainder_ComprehensiveNetIncome 657
  yvar yval
0 Assets 574,275
1 Liabilities 29,438
2 Expenses 232,789
3 Revenues 0
4 StockholdersEquity 544,837
5 NetIncome -234,889
6 ComprehensiveNetIncome -234,560
7 BaseVar 419,630
8 EconomicCapitalRatiobeforeLimitedLiability 3.16
9 EconomicCapitalRatio 3.79

Edgar->Model Mapping

Feature Distribution

Change over Time